{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T10:04:01Z","timestamp":1788084241911,"version":"build-2784847793"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute of Health USA and Dept of Vet Affairs, USA","award":["AG086245, IK6BX004212, BX006456"],"award-info":[{"award-number":["AG086245, IK6BX004212, BX006456"]}]},{"name":"National Institute of Health,USA and Dept of Veteran Affairs USA","award":["AG086245, IK6BX006032, BX005757"],"award-info":[{"award-number":["AG086245, IK6BX006032, BX005757"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alzheimer\u2019s disease (AD) and Alzheimer\u2019s disease\u2013related dementias (ADRD) are multifactorial neurodegenerative disorders driven by complex interactions among genetic susceptibility, aging, and environmental exposures. Growing epidemiological and mechanistic evidence implicates neurotropic viral exposomes, defined as cumulative lifetime viral infections, as significant contributors to AD risk. Viral encephalitis and common viral infections, including herpes simplex virus type 1 (HSV-1), human immunodeficiency virus (HIV), cytomegalovirus (CMV), SARS-CoV-2, and influenza, have been associated with an increased incidence of AD\/ADRD; however, the molecular mechanisms underlying these associations remain incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic literature review was conducted using PubMed, Web of Science, Scopus, and Google Scholar (1990\u20132025) to identify epidemiological, experimental, and mechanistic studies linking viral infections to AD-related pathology. Systems biology approaches were applied using Cytoscape, STRING, KEGG, WikiPathways, and Ingenuity Pathway Analysis to construct protein\u2013protein interaction networks and identify convergent biological processes shared between AD and viral host-response pathways. Functional enrichment analyses focused on neuroinflammation, amyloid-\u03b2 (A\u03b2) metabolism, tau pathology, autophagy, and blood\u2013brain barrier (BBB) integrity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Across diverse viral infections, strong convergence was observed in innate immune activation pathways, including microglial priming and NLRP3 inflammasome signaling, accompanied by chronic production of proinflammatory cytokines (IL-1\u03b2, TNF-\u03b1, IFN-\u03b3). Multiple viruses modulated amyloidogenic APP processing, impaired A\u03b2 clearance, promoted tau hyperphosphorylation, disrupted autophagy-lysosomal systems, and compromised BBB integrity. Systems-level analyses revealed overlapping signaling hubs, including NF-\u03baB, MAPK, PI3K-Akt, and cGAS-STING that amplify neurodegenerative cascades, with effects most pronounced in genetically susceptible populations such as APOE4 carriers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collectively, current evidence supports a mechanistic link between viral exposomes and AD\/ADRD mediated through convergent neuroinflammatory, and proteostatic pathways. Although viral infections alone are unlikely to be sufficient to cause AD, recurrent or persistent viral exposures may act as potent disease modifiers that accelerate neurodegenerative processes. Integrating viral biomarkers, genetic risk stratification, and systems biology approaches offers promising opportunities for early diagnosis, prevention, and development of mechanism-guided therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-026-03876-2","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:54:46Z","timestamp":1780048486000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Convergence of neuroinflammation across major neurotropic viral exposomes in AD and ADRD"],"prefix":"10.1186","volume":"23","author":[{"given":"Jamile","family":"Harmouch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthick","family":"Mayilsamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Tosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhra","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam S","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"3876_CR1","doi-asserted-by":"publisher","unstructured":"Agnello L, Ciaccio M. Neurodegenerative diseases: from molecular basis to therapy. Int J Mol Sci. 2022;25(21). https:\/\/doi.org\/10.3390\/ijms232112854.","DOI":"10.3390\/ijms232112854"},{"issue":"6","key":"3876_CR2","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson O. Biomarkers for neurodegenerative diseases. Nat Med. 2021;27(6):954\u201363. https:\/\/doi.org\/10.1038\/s41591-021-01382-x.","journal-title":"Nat Med"},{"key":"3876_CR3","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","volume":"5","author":"D Su","year":"2025","unstructured":"Su D, Cui Y, He C, et al. Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ. 2025;5:388:e080952. https:\/\/doi.org\/10.1136\/bmj-2024-080952.","journal-title":"BMJ"},{"issue":"5","key":"3876_CR4","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1002\/alz.13809","volume":"20","author":"Alzheimer\u2019s disease facts and figures","year":"2024","unstructured":"2024Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2024;20(5):3708\u2013821. https:\/\/doi.org\/10.1002\/alz.13809.","journal-title":"Alzheimers Dement"},{"key":"3876_CR5","doi-asserted-by":"publisher","unstructured":"Birajdar SV, Mulchandani M, Mazahir F, Yadav AK. Dementia and neurodegenerative disorder: An introduction. In: Kesharwani P, editor. Nanomedicine-Based Approaches for the Treatment of Dementia. Elsevier Inc.; 2023. pp. 1\u201336. https:\/\/doi.org\/10.1016\/B978-0-12-824331-2.00007-8.","DOI":"10.1016\/B978-0-12-824331-2.00007-8"},{"issue":"11","key":"3876_CR6","doi-asserted-by":"publisher","first-page":"e1010929","DOI":"10.1371\/journal.ppat.1010929","volume":"18","author":"I Vojtechova","year":"2022","unstructured":"Vojtechova I, Machacek T, Kristofikova Z, Stuchlik A, Petrasek T. Infectious origin of Alzheimer\u2019s disease: Amyloid beta as a component of brain antimicrobial immunity. PLoS Pathog. 2022;18(11):e1010929. https:\/\/doi.org\/10.1371\/journal.ppat.1010929.","journal-title":"PLoS Pathog"},{"key":"3876_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fnagi.2018.00224","volume":"10","author":"T Fulop","year":"2018","unstructured":"Fulop T, Witkowski JM, Bourgade K, et al. Can an infection hypothesis explain the beta amyloid hypothesis of alzheimer\u2019s disease? Front Aging Neurosci. 2018;10:224. https:\/\/doi.org\/10.3389\/fnagi.2018.00224.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"3876_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/s0925-4439(00)00029-6","volume":"26","author":"LC Serpell","year":"2000","unstructured":"Serpell LC. Alzheimer\u2019s amyloid fibrils: structure and assembly. Biochim Biophys Acta. 2000;26(1):16\u201330. https:\/\/doi.org\/10.1016\/s0925-4439(00)00029-6.","journal-title":"Biochim Biophys Acta Jul"},{"issue":"2","key":"3876_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/10520290903389445","volume":"85","author":"MR D\u2019Andrea","year":"2010","unstructured":"D\u2019Andrea MR, Nagele RG. Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer\u2019s disease pathogenesis. Biotech Histochem. 2010;85(2):133\u201347. https:\/\/doi.org\/10.3109\/10520290903389445.","journal-title":"Biotech Histochem"},{"issue":"9","key":"3876_CR10","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1093\/brain\/awab134","volume":"22","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang Y, Aman Y, et al. Amyloid-beta toxicity modulates tau phosphorylation through the PAX6 signalling pathway. Brain. 2021;22(9):2759\u201370. https:\/\/doi.org\/10.1093\/brain\/awab134.","journal-title":"Brain"},{"key":"3876_CR11","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","volume":"15","author":"S Muralidar","year":"2020","unstructured":"Muralidar S, Ambi SV, Sekaran S, Thirumalai D, Palaniappan B. Role of tau protein in Alzheimer\u2019s disease: The prime pathological player. Int J Biol Macromol. 2020;15:163:1599\u2013617. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.07.327.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"3876_CR12","doi-asserted-by":"publisher","first-page":"6635","DOI":"10.1038\/s41467-022-34129-4","volume":"4","author":"A Pichet Binette","year":"2022","unstructured":"Pichet Binette A, Franzmeier N, Spotorno N, et al. Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer\u2019s disease. Nat Commun. 2022;4(1):6635. https:\/\/doi.org\/10.1038\/s41467-022-34129-4.","journal-title":"Nat Commun"},{"issue":"7","key":"3876_CR13","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1007\/s12035-022-02850-2","volume":"59","author":"D Lyu","year":"2022","unstructured":"Lyu D, Jia J. Cryptotanshinone Attenuates Amyloid-beta(42)-induced Tau phosphorylation by regulating PI3K\/Akt\/GSK3beta pathway in HT22 Cells. Mol Neurobiol. 2022;59(7):4488\u2013500. https:\/\/doi.org\/10.1007\/s12035-022-02850-2.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"3876_CR14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405. https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5.","journal-title":"Lancet Neurol"},{"issue":"4","key":"3876_CR15","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-180098","volume":"63","author":"Z Cai","year":"2018","unstructured":"Cai Z, Qiao PF, Wan CQ, Cai M, Zhou NK, Li Q. Role of blood-brain barrier in alzheimer\u2019s disease. J Alzheimers Dis. 2018;63(4):1223\u201334. https:\/\/doi.org\/10.3233\/JAD-180098.","journal-title":"J Alzheimers Dis"},{"key":"3876_CR16","doi-asserted-by":"publisher","unstructured":"Pisani FPV, Arcangeli F, Harding A, Singhrao SK. The mechanistic pathways of periodontal pathogens entering the brain: the potential role of Treponema denticola in tracing Alzheimer\u2019s disease pathology. Int J Environ Res Public Health. 2022;19(15):9386. https:\/\/doi.org\/10.3390\/ijerph19159386.","DOI":"10.3390\/ijerph19159386"},{"issue":"6","key":"3876_CR17","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.14336\/AD.2022.0412","volume":"1","author":"T Wu","year":"2022","unstructured":"Wu T, Lin D, Cheng Y, et al. Amyloid cascade hypothesis for the treatment of alzheimer\u2019s disease: progress and challenges. Aging Dis. 2022;1(6):1745\u201358. https:\/\/doi.org\/10.14336\/AD.2022.0412.","journal-title":"Aging Dis"},{"issue":"12","key":"3876_CR18","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","volume":"21","author":"RA Sperling","year":"2023","unstructured":"Sperling RA, Donohue MC, Raman R, et al. Trial of solanezumab in preclinical alzheimer\u2019s disease. N Engl J Med. 2023;21(12):1096\u2013107. https:\/\/doi.org\/10.1056\/NEJMoa2305032.","journal-title":"N Engl J Med"},{"key":"3876_CR19","doi-asserted-by":"publisher","first-page":"907804","DOI":"10.3389\/fimmu.2022.907804","volume":"13","author":"VTA Tran","year":"2022","unstructured":"Tran VTA, Lee LP, Cho H. Neuroinflammation in neurodegeneration via microbial infections. Front Immunol. 2022;13:907804. https:\/\/doi.org\/10.3389\/fimmu.2022.907804.","journal-title":"Front Immunol"},{"issue":"4","key":"3876_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41582-020-0323-9","volume":"16","author":"RF Itzhaki","year":"2020","unstructured":"Itzhaki RF, Golde TE, Heneka MT, Readhead B. Do infections have a role in the pathogenesis of Alzheimer disease? Nat Rev Neurol. 2020;16(4):193\u20137. https:\/\/doi.org\/10.1038\/s41582-020-0323-9.","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"3876_CR21","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neuron.2022.12.029","volume":"5","author":"KS Levine","year":"2023","unstructured":"Levine KS, Leonard HL, Blauwendraat C, et al. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron. 2023;5(7):1086\u2013e10932. https:\/\/doi.org\/10.1016\/j.neuron.2022.12.029.","journal-title":"Neuron"},{"issue":"1","key":"3876_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"12","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;12(1):267. https:\/\/doi.org\/10.1038\/s41392-023-01486-5.","journal-title":"Signal Transduct Target Ther"},{"key":"3876_CR23","doi-asserted-by":"publisher","first-page":"102068","DOI":"10.1016\/j.arr.2023.102068","volume":"91","author":"F Bruno","year":"2023","unstructured":"Bruno F, Abondio P, Bruno R, et al. Alzheimer\u2019s disease as a viral disease: revisiting the infectious hypothesis. Ageing Res Rev. 2023;91:102068. https:\/\/doi.org\/10.1016\/j.arr.2023.102068.","journal-title":"Ageing Res Rev"},{"issue":"4","key":"3876_CR24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/jmv.1890330403","volume":"33","author":"GA Jamieson","year":"1991","unstructured":"Jamieson GA, Maitland NJ, Wilcock GK, Craske J, Itzhaki RF. Latent herpes simplex virus type 1 in normal and Alzheimer\u2019s disease brains. J Med Virol. 1991;33(4):224\u20137. https:\/\/doi.org\/10.1002\/jmv.1890330403.","journal-title":"J Med Virol"},{"key":"3876_CR25","doi-asserted-by":"publisher","unstructured":"Eimer WA, Rodriguez AS, DeFao MT, et al. Phosphorylated tau exhibits antimicrobial activity capable of neutralizing herpes simplex virus 1 infectivity in human neurons. Nat Neurosci. 2025;17. https:\/\/doi.org\/10.1038\/s41593-025-02157-0.","DOI":"10.1038\/s41593-025-02157-0"},{"key":"3876_CR26","doi-asserted-by":"publisher","unstructured":"Gorzek RC, Joly-Amado A, Hurst-Calle N, et al. Adeno-Associated viral gene delivery of wild-type human tau induces progressive hyperphosphorylation and neuronal cell death in the hippocampi of middle-aged rats. Cells. 2025;11(16). https:\/\/doi.org\/10.3390\/cells14161238.","DOI":"10.3390\/cells14161238"},{"key":"3876_CR27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fnagi.2014.00202","volume":"6","author":"RF Itzhaki","year":"2014","unstructured":"Itzhaki RF. Herpes simplex virus type 1 and Alzheimer\u2019s disease: increasing evidence for a major role of the virus. Front Aging Neurosci. 2014;6:202. https:\/\/doi.org\/10.3389\/fnagi.2014.00202.","journal-title":"Front Aging Neurosci"},{"key":"3876_CR28","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3389\/fimmu.2020.01629","volume":"11","author":"EY Lee","year":"2020","unstructured":"Lee EY, Srinivasan Y, de Anda J, Nicastro LK, T\u00fckel \u00c7, Wong GCL. Functional reciprocity of amyloids and antimicrobial peptides: rethinking the role of supramolecular assembly in host defense, immune activation, and inflammation. Front Immunol. 2020;11:1629. https:\/\/doi.org\/10.3389\/fimmu.2020.01629.","journal-title":"Front Immunol"},{"key":"3876_CR29","doi-asserted-by":"publisher","unstructured":"De Chiara G, Piacentini R, Fabiani M et al. Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice. 2019. https:\/\/doi.org\/10.1371\/journal.ppat.1007617.","DOI":"10.1371\/journal.ppat.1007617"},{"key":"3876_CR30","doi-asserted-by":"publisher","unstructured":"Ijezie EC, Miller MJ, Hardy C, et al. HSV-1 infection alters MAPT splicing and promotes tau pathology in neural models of Alzheimer\u2019s disease. https:\/\/doi.org\/10.1111\/bpa.70006.","DOI":"10.1111\/bpa.70006"},{"issue":"2","key":"3876_CR31","doi-asserted-by":"publisher","first-page":"2216625","DOI":"10.1080\/21645515.2023.2216625","volume":"1","author":"AS Bukhbinder","year":"2023","unstructured":"Bukhbinder AS, Ling Y, Harris K, Jiang X, Schulz PE. Do vaccinations influence the development of Alzheimer disease? Hum Vaccin Immunother. 2023;1(2):2216625. https:\/\/doi.org\/10.1080\/21645515.2023.2216625.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"3876_CR32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12974-023-02945-0","volume":"21","author":"O Cousins","year":"2023","unstructured":"Cousins O, Schubert JJ, Chandra A, et al. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal\/multi-tracer PET\/MRI imaging study with influenza vaccine immune challenge. J Neuroinflammation. 2023;21(1):272. https:\/\/doi.org\/10.1186\/s12974-023-02945-0.","journal-title":"J Neuroinflammation"},{"key":"3876_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(24)00003-7","author":"MWK Kivimaki","year":"2024","unstructured":"Kivimaki MWK. Vaccination and the risk of dementia. Lancet Healthy Longev. 2024. https:\/\/doi.org\/10.1016\/S2666-7568(24)00003-7.","journal-title":"Lancet Healthy Longev"},{"key":"3876_CR34","doi-asserted-by":"publisher","first-page":"117316","DOI":"10.1016\/j.jns.2021.117316","volume":"15","author":"A Lewis","year":"2021","unstructured":"Lewis A, Frontera J, Placantonakis DG, et al. Cerebrospinal fluid in COVID-19: a systematic review of the literature. J Neurol Sci. 2021;15:421:117316. https:\/\/doi.org\/10.1016\/j.jns.2021.117316.","journal-title":"J Neurol Sci"},{"issue":"4","key":"3876_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/jamapsychiatry.2021.4377","volume":"1","author":"LS Richmond-Rakerd","year":"2022","unstructured":"Richmond-Rakerd LS, D\u2019Souza S, Milne BJ, Caspi A, Moffitt TE. Longitudinal associations of mental disorders with dementia: 30-year analysis of 1.7 million New Zealand Citizens. JAMA Psychiatry. 2022;1(4):333\u201340. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.4377.","journal-title":"JAMA Psychiatry"},{"key":"3876_CR36","doi-asserted-by":"publisher","unstructured":"Velikic G, Supic G, Maric DL, et al. Neurodegeneration as ecosystem failure: a new paradigm for prevention and treatment. Int J Mol Sci. 2025;20(22). https:\/\/doi.org\/10.3390\/ijms262211207.","DOI":"10.3390\/ijms262211207"},{"issue":"2","key":"3876_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11481-018-9821-6","volume":"14","author":"H Liu","year":"2019","unstructured":"Liu H, Qiu K, He Q, Lei Q, Lu W. Mechanisms of blood-brain barrier disruption in herpes simplex encephalitis. J Neuroimmune Pharmacol. 2019;14(2):157\u201372. https:\/\/doi.org\/10.1007\/s11481-018-9821-6.","journal-title":"J Neuroimmune Pharmacol"},{"key":"3876_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-1-0716-4615-1_19","volume":"2940","author":"Z Huang","year":"2025","unstructured":"Huang Z, Peng L, Zheng C, Sun W. The application of HSV-1 in investigating neurological diseases. Methods Mol Biol. 2025;2940:207\u201313. https:\/\/doi.org\/10.1007\/978-1-0716-4615-1_19.","journal-title":"Methods Mol Biol"},{"issue":"2\u20133","key":"3876_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neulet.2007.09.077","volume":"18","author":"MA Wozniak","year":"2007","unstructured":"Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB. Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci Lett. 2007;18(2\u20133):95\u2013100. https:\/\/doi.org\/10.1016\/j.neulet.2007.09.077.","journal-title":"Neurosci Lett"},{"key":"3876_CR40","doi-asserted-by":"publisher","unstructured":"Gu L, Liu C, Stroud JC, Ngo S, Jiang L, Guo Z. Antiparallel triple-strand architecture for prefibrillar A\u03b242 oligomers. J Biol Chem. 2014;289(39):27300\u201313. https:\/\/doi.org\/10.1074\/jbc.M114.569004.","DOI":"10.1074\/jbc.M114.569004"},{"issue":"1","key":"3876_CR41","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12974-024-03166-9","volume":"18","author":"Z Wang","year":"2024","unstructured":"Wang Z, Liu J, Han J, et al. Herpes simplex virus 1 accelerates the progression of Alzheimer\u2019s disease by modulating microglial phagocytosis and activating NLRP3 pathway. J Neuroinflammation. 2024;18(1):176. https:\/\/doi.org\/10.1186\/s12974-024-03166-9.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"3876_CR42","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/bab.2233","volume":"69","author":"M Asadi","year":"2022","unstructured":"Asadi M, Taghizadeh S, Kaviani E, et al. Caspase-3: Structure, function, and biotechnological aspects. Biotechnol Appl Biochem. 2022;69(4):1633\u201345. https:\/\/doi.org\/10.1002\/bab.2233.","journal-title":"Biotechnol Appl Biochem"},{"issue":"1","key":"3876_CR43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41398-023-02376-8","volume":"10","author":"MA Albaret","year":"2023","unstructured":"Albaret MA, Textoris J, Dalzon B, et al. HSV-1 cellular model reveals links between aggresome formation and early step of Alzheimer\u2019s disease. Transl Psychiatry. 2023;10(1):86. https:\/\/doi.org\/10.1038\/s41398-023-02376-8.","journal-title":"Transl Psychiatry"},{"key":"3876_CR44","doi-asserted-by":"publisher","unstructured":"Rahman MA, Rahman MDH, Mamun-Or-Rashid ANM, et al. Autophagy modulation in aggresome formation: emerging implications and treatments of alzheimer\u2019s disease. Biomedicines. 2022;29(5). https:\/\/doi.org\/10.3390\/biomedicines10051027.","DOI":"10.3390\/biomedicines10051027"},{"issue":"5","key":"3876_CR45","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1128\/JVI.65.5.2666-2675.1991","volume":"65","author":"M Gao","year":"1991","unstructured":"Gao M, Knipe DM. Potential role for herpes simplex virus ICP8 DNA replication protein in stimulation of late gene expression. J Virol. 1991;65(5):2666\u201375. https:\/\/doi.org\/10.1128\/JVI.65.5.2666-2675.1991.","journal-title":"J Virol"},{"key":"3876_CR46","doi-asserted-by":"publisher","unstructured":"Corsi A, Bombieri C, Valenti MT, Romanelli MG. Tau isoforms: gaining insight into MAPT alternative splicing. Int J Mol Sci. 2022;6(23). https:\/\/doi.org\/10.3390\/ijms232315383.","DOI":"10.3390\/ijms232315383"},{"issue":"5","key":"3876_CR47","doi-asserted-by":"publisher","first-page":"e70006","DOI":"10.1111\/bpa.70006","volume":"35","author":"EC Ijezie","year":"2025","unstructured":"Ijezie EC, Miller MJ, Hardy C, et al. Herpes simplex virus-1 infection alters microtubule-associated protein Tau splicing and promotes Tau pathology in neural models of Alzheimer\u2019s disease. Brain Pathol. 2025;35(5):e70006. https:\/\/doi.org\/10.1111\/bpa.70006.","journal-title":"Brain Pathol"},{"issue":"7784","key":"3876_CR48","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575(7784):669\u201373. https:\/\/doi.org\/10.1038\/s41586-019-1769-z.","journal-title":"Nature"},{"key":"3876_CR49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-1326-2-12","volume":"28","author":"CA Rankin","year":"2007","unstructured":"Rankin CA, Sun Q, Gamblin TC. Tau phosphorylation by GSK-3beta promotes tangle-like filament morphology. Mol Neurodegener. 2007;28:2:12. https:\/\/doi.org\/10.1186\/1750-1326-2-12.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"3876_CR50","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3233\/JAD-131843","volume":"37","author":"I Morales","year":"2013","unstructured":"Morales I, Jimenez JM, Mancilla M, Maccioni RB. Tau oligomers and fibrils induce activation of microglial cells. J Alzheimers Dis. 2013;37(4):849\u201356. https:\/\/doi.org\/10.3233\/JAD-131843.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"3876_CR51","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/15548627.2016.1139262","volume":"12","author":"D O\u2019Connell","year":"2016","unstructured":"O\u2019Connell D, Liang C. Autophagy interaction with herpes simplex virus type-1 infection. Autophagy. 2016;12(3):451\u20139. https:\/\/doi.org\/10.1080\/15548627.2016.1139262.","journal-title":"Autophagy"},{"key":"3876_CR52","doi-asserted-by":"publisher","unstructured":"Houtman J, Freitag K, Gimber N, Schmoranzer J, Heppner FL, Jendrach M. Beclin1-driven autophagy modulates the inflammatory response of microglia via NLRP3. EMBO J. 2019;15(4). https:\/\/doi.org\/10.15252\/embj.201899430.","DOI":"10.15252\/embj.201899430"},{"issue":"4","key":"3876_CR53","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1128\/IAI.06146-11","volume":"80","author":"SC Cheng","year":"2012","unstructured":"Cheng SC, Joosten LA, Kullberg BJ, Netea MG. Interplay between Candida albicans and the mammalian innate host defense. Infect Immun. 2012;80(4):1304\u201313. https:\/\/doi.org\/10.1128\/IAI.06146-11.","journal-title":"Infect Immun"},{"key":"3876_CR54","doi-asserted-by":"publisher","unstructured":"Mustafa M, Musselman D, Jayaweera D, da Fonseca Ferreira A, Marzouka G, Dong C. HIV-associated neurocognitive disorder (HAND) and alzheimer\u2019s disease pathogenesis: future directions for diagnosis and treatment. Int J Mol Sci. 2024;17(20). https:\/\/doi.org\/10.3390\/ijms252011170.","DOI":"10.3390\/ijms252011170"},{"issue":"5","key":"3876_CR55","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s13365-019-00736-z","volume":"25","author":"A Hategan","year":"2019","unstructured":"Hategan A, Masliah E, Nath A. HIV and Alzheimer\u2019s disease: complex interactions of HIV-Tat with amyloid beta peptide and Tau protein. J Neurovirol. 2019;25(5):648\u201360. https:\/\/doi.org\/10.1007\/s13365-019-00736-z.","journal-title":"J Neurovirol"},{"issue":"3","key":"3876_CR56","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12640-009-9047-8","volume":"16","author":"W Li","year":"2009","unstructured":"Li W, Li G, Steiner J, Nath A. Role of Tat protein in HIV neuropathogenesis. Neurotox Res. 2009;16(3):205\u201320. https:\/\/doi.org\/10.1007\/s12640-009-9047-8.","journal-title":"Neurotox Res"},{"key":"3876_CR57","doi-asserted-by":"publisher","unstructured":"Abdallah IM, Al-Shami KM, Yang E, Kaddoumi A. Blood-brain barrier disruption increases amyloid-related pathology in TgSwDI Mice. Int J Mol Sci. 2021;27(3). https:\/\/doi.org\/10.3390\/ijms22031231.","DOI":"10.3390\/ijms22031231"},{"issue":"4","key":"3876_CR58","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nsmb.3379","volume":"24","author":"A Hategan","year":"2017","unstructured":"Hategan A, Bianchet MA, Steiner J, et al. HIV Tat protein and amyloid-beta peptide form multifibrillar structures that cause neurotoxicity. Nat Struct Mol Biol. 2017;24(4):379\u201386. https:\/\/doi.org\/10.1038\/nsmb.3379.","journal-title":"Nat Struct Mol Biol"},{"issue":"10","key":"3876_CR59","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.bpj.2010.01.056","volume":"19","author":"EY Chi","year":"2010","unstructured":"Chi EY, Frey SL, Winans A, et al. Amyloid-beta fibrillogenesis seeded by interface-induced peptide misfolding and self-assembly. Biophys J. 2010;19(10):2299\u2013308. https:\/\/doi.org\/10.1016\/j.bpj.2010.01.056.","journal-title":"Biophys J"},{"key":"3876_CR60","doi-asserted-by":"publisher","unstructured":"Jana AK, Keskin R, Ya\u015far F. Molecular Insight into the Effect of HIV-TAT Protein on Amyloid-\u03b2 Peptides. ACS Omega. 2024;9(25):27480\u201391. https:\/\/doi.org\/10.1021\/acsomega.4c02643.","DOI":"10.1021\/acsomega.4c02643"},{"issue":"7","key":"3876_CR61","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s12272-021-01340-8","volume":"44","author":"YJ Lee","year":"2021","unstructured":"Lee YJ, Yeo IJ, Choi DY, et al. Amyloidogenic, neuroinflammatory and memory dysfunction effects of HIV-1 gp120. Arch Pharm Res. 2021;44(7):689\u2013701. https:\/\/doi.org\/10.1007\/s12272-021-01340-8.","journal-title":"Arch Pharm Res"},{"issue":"29","key":"3876_CR62","doi-asserted-by":"publisher","first-page":"10550","DOI":"10.1523\/JNEUROSCI.4403-14.2015","volume":"22","author":"L Festa","year":"2015","unstructured":"Festa L, Gutoskey CJ, Graziano A, Waterhouse BD, Meucci O. Induction of interleukin-1beta by human immunodeficiency virus-1 viral proteins leads to increased levels of neuronal ferritin heavy chain, synaptic injury, and deficits in flexible attention. J Neurosci. 2015;22(29):10550\u201361. https:\/\/doi.org\/10.1523\/JNEUROSCI.4403-14.2015.","journal-title":"J Neurosci"},{"issue":"4","key":"3876_CR63","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1007\/s12035-024-04543-4","volume":"62","author":"ZL Almeida","year":"2025","unstructured":"Almeida ZL, Vaz DC, Brito RMM. Morphological and molecular profiling of amyloid-beta species in alzheimer\u2019s pathogenesis. Mol Neurobiol. 2025;62(4):4391\u2013419. https:\/\/doi.org\/10.1007\/s12035-024-04543-4.","journal-title":"Mol Neurobiol"},{"issue":"6","key":"3876_CR64","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1016\/j.apsb.2022.01.002","volume":"12","author":"Z Ju","year":"2022","unstructured":"Ju Z, Li M, Xu J, Howell DC, Li Z, Chen FE. Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years. Acta Pharm Sin B. 2022;12(6):2790\u2013807. https:\/\/doi.org\/10.1016\/j.apsb.2022.01.002.","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"3876_CR65","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/infdis\/jit210","volume":"15","author":"NS Lurain","year":"2013","unstructured":"Lurain NS, Hanson BA, Martinson J, et al. Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis. 2013;15(4):564\u201372. https:\/\/doi.org\/10.1093\/infdis\/jit210.","journal-title":"J Infect Dis"},{"issue":"3","key":"3876_CR66","doi-asserted-by":"publisher","first-page":"e2034","DOI":"10.1002\/rmv.2034","volume":"29","author":"M Zuhair","year":"2019","unstructured":"Zuhair M, Smit GSA, Wallis G, et al. Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis. Rev Med Virol. 2019;29(3):e2034. https:\/\/doi.org\/10.1002\/rmv.2034.","journal-title":"Rev Med Virol"},{"issue":"2","key":"3876_CR67","doi-asserted-by":"publisher","first-page":"422","DOI":"10.14283\/jpad.2023.126","volume":"11","author":"Q Ji","year":"2024","unstructured":"Ji Q, Lian W, Meng Y, et al. Cytomegalovirus infection and alzheimer\u2019s disease: a meta-analysis. J Prev Alzheimers Dis. 2024;11(2):422\u20137. https:\/\/doi.org\/10.14283\/jpad.2023.126.","journal-title":"J Prev Alzheimers Dis"},{"key":"3876_CR68","doi-asserted-by":"publisher","unstructured":"Blanck G, Huda TI, Chobrutskiy BI, Chobrutskiy A. CMV as a factor in the development of Alzheimer's disease? Med Hypotheses. 2023;178:111140. https:\/\/doi.org\/10.1016\/j.mehy.2023.111140.","DOI":"10.1016\/j.mehy.2023.111140"},{"issue":"4","key":"3876_CR69","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s13365-022-01109-9","volume":"29","author":"PH Mody","year":"2023","unstructured":"Mody PH, Marvin KN, Hynds DL, Hanson LK. Cytomegalovirus infection induces Alzheimer\u2019s disease-associated alterations in tau. J Neurovirol. 2023;29(4):400\u201315. https:\/\/doi.org\/10.1007\/s13365-022-01109-9.","journal-title":"J Neurovirol"},{"issue":"12","key":"3876_CR70","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrd.2017.155","volume":"16","author":"C Li","year":"2017","unstructured":"Li C, Gotz J. Tau-based therapies in neurodegeneration: opportunities and challenges. Nat Rev Drug Discov. 2017;16(12):863\u201383. https:\/\/doi.org\/10.1038\/nrd.2017.155.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"3876_CR71","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3233\/JAD-230220","volume":"98","author":"DC Parker","year":"2024","unstructured":"Parker DC, Whitson HE, Smith PJ, et al. Anti-CMV IgG Seropositivity is associated with plasma biomarker evidence of amyloid-beta accumulation. J Alzheimers Dis. 2024;98(2):593\u2013600. https:\/\/doi.org\/10.3233\/JAD-230220.","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"3876_CR72","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1096\/fj.15-275834","volume":"29","author":"A Li","year":"2015","unstructured":"Li A, Ceballos-Diaz C, DiNunno N, et al. IFN-gamma promotes tau phosphorylation without affecting mature tangles. FASEB J. 2015;29(10):4384\u201398. https:\/\/doi.org\/10.1096\/fj.15-275834.","journal-title":"FASEB J"},{"issue":"5","key":"3876_CR73","doi-asserted-by":"publisher","first-page":"e96779","DOI":"10.1371\/journal.pone.0096779","volume":"9","author":"G Westman","year":"2014","unstructured":"Westman G, Berglund D, Widen J, et al. Increased inflammatory response in cytomegalovirus seropositive patients with Alzheimer\u2019s disease. PLoS ONE. 2014;9(5):e96779. https:\/\/doi.org\/10.1371\/journal.pone.0096779.","journal-title":"PLoS ONE"},{"issue":"2","key":"3876_CR74","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/pin.12502","volume":"67","author":"H Kawasaki","year":"2017","unstructured":"Kawasaki H, Kosugi I, Meguro S, Iwashita T. Pathogenesis of developmental anomalies of the central nervous system induced by congenital cytomegalovirus infection. Pathol Int. 2017;67(2):72\u201382. https:\/\/doi.org\/10.1111\/pin.12502.","journal-title":"Pathol Int"},{"key":"3876_CR75","doi-asserted-by":"publisher","first-page":"152057","DOI":"10.1016\/j.anndiagpath.2022.152057","volume":"61","author":"GJ Nuovo","year":"2022","unstructured":"Nuovo GJ, Suster D, Sawant D, Mishra A, Michaille JJ, Tili E. The amplification of CNS damage in Alzheimer\u2019s disease due to SARS-CoV2 infection. Ann Diagn Pathol. 2022;61:152057. https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.152057.","journal-title":"Ann Diagn Pathol"},{"key":"3876_CR76","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.omtm.2022.09.007","volume":"8","author":"R Green","year":"2022","unstructured":"Green R, Mayilsamy K, McGill AR, et al. SARS-CoV-2 infection increases the gene expression profile for Alzheimer\u2019s disease risk. Mol Ther Methods Clin Dev. 2022;8:27:217\u201329. https:\/\/doi.org\/10.1016\/j.omtm.2022.09.007.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"35","key":"3876_CR77","doi-asserted-by":"publisher","first-page":"e2200960119","DOI":"10.1073\/pnas.2200960119","volume":"30","author":"F Crunfli","year":"2022","unstructured":"Crunfli F, Carregari VC, Veras FP, et al. Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proc Natl Acad Sci U S A. 2022;30(35):e2200960119. https:\/\/doi.org\/10.1073\/pnas.2200960119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3876_CR78","doi-asserted-by":"publisher","unstructured":"Green R, Mayilsamy K, McGill AR et al. SARS-CoV-2 infection increases the gene expression profile for Alzheimer\u2019s disease risk. 2022. https:\/\/doi.org\/10.1016\/j.omtm.2022.09.007.","DOI":"10.1016\/j.omtm.2022.09.007"},{"key":"3876_CR79","doi-asserted-by":"publisher","unstructured":"Chiricosta L, Gugliandolo A, Mazzon E. SARS-CoV-2 Exacerbates beta-amyloid neurotoxicity, inflammation and oxidative stress in alzheimer\u2019s disease patients. Int J Mol Sci. 2021;19(24). https:\/\/doi.org\/10.3390\/ijms222413603.","DOI":"10.3390\/ijms222413603"},{"issue":"1","key":"3876_CR80","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41398-023-02692-z","volume":"16","author":"J Chen","year":"2023","unstructured":"Chen J, Chen J, Lei Z, et al. Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-beta-associated pathology in APP\/PS1 mouse model of Alzheimer\u2019s disease. Transl Psychiatry. 2023;16(1):396. https:\/\/doi.org\/10.1038\/s41398-023-02692-z.","journal-title":"Transl Psychiatry"},{"key":"3876_CR81","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bbrc.2021.03.100","volume":"21","author":"D Idrees","year":"2021","unstructured":"Idrees D, Kumar V. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration. Biochem Biophys Res Commun. 2021;21:554:94\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2021.03.100.","journal-title":"Biochem Biophys Res Commun"},{"key":"3876_CR82","doi-asserted-by":"publisher","first-page":"1280600","DOI":"10.3389\/fcimb.2023.1280600","volume":"13","author":"B Marwaha","year":"2023","unstructured":"Marwaha B. Role of Tau protein in long COVID and potential therapeutic targets. Front Cell Infect Microbiol. 2023;13:1280600. https:\/\/doi.org\/10.3389\/fcimb.2023.1280600.","journal-title":"Front Cell Infect Microbiol"},{"key":"3876_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01213-1","author":"SBA Dozak","year":"2023","unstructured":"Dozak SBA, Cooke M, Yeomans DC. COVID-19 and dementia: a potential connection through Alzheimer\u2019s pathways. Alzheimers Res Ther. 2023. https:\/\/doi.org\/10.1186\/s13195-023-01213-1.","journal-title":"Alzheimers Res Ther"},{"key":"3876_CR84","doi-asserted-by":"publisher","unstructured":"Pratt J, Lester E, Parker R. Jul. Could SARS-CoV-2 cause tauopathy? Lancet Neurol. 2021;20(7):506. https:\/\/doi.org\/10.1016\/S1474-4422(21)00168-X.","DOI":"10.1016\/S1474-4422(21)00168-X"},{"key":"3876_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00650-y","author":"JJH Xi","year":"2021","unstructured":"Xi JJH, Zhao K. NLRP3 inflammasome inhibitors as potential therapeutics for COVID-19. Signal Transduct Target Ther. 2021. https:\/\/doi.org\/10.1038\/s41392-021-00650-y.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"3876_CR86","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","volume":"185","author":"A Fu","year":"2022","unstructured":"Fu A, Yao B, Dong T, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell. 2022;185(8):1356\u201372 e26. https:\/\/doi.org\/10.1016\/j.cell.2022.02.027.","journal-title":"Cell"},{"issue":"11","key":"3876_CR87","doi-asserted-by":"publisher","first-page":"e14352","DOI":"10.1111\/acel.14352","volume":"23","author":"X Qi","year":"2024","unstructured":"Qi X, Yuan S, Ding J, et al. Emerging signs of Alzheimer-like tau hyperphosphorylation and neuroinflammation in the brain post recovery from COVID-19. Aging Cell. 2024;23(11):e14352. https:\/\/doi.org\/10.1111\/acel.14352.","journal-title":"Aging Cell"},{"issue":"1","key":"3876_CR88","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.7861\/clinmed.2020-0896","volume":"21","author":"M Dani","year":"2021","unstructured":"Dani M, Dirksen A, Taraborrelli P, et al. Autonomic dysfunction in \u2018long COVID\u2019: rationale, physiology and management strategies. Clin Med (Lond). 2021;21(1):e63\u20137. https:\/\/doi.org\/10.7861\/clinmed.2020-0896.","journal-title":"Clin Med (Lond)"},{"key":"3876_CR89","doi-asserted-by":"publisher","first-page":"1439055","DOI":"10.3389\/fnins.2024.1439055","volume":"18","author":"M Zhao","year":"2024","unstructured":"Zhao M, Wang Y, Shen Y, Wei C, Zhang G, Sun L. A review of the roles of pathogens in Alzheimer\u2019s disease. Front Neurosci. 2024;18:1439055. https:\/\/doi.org\/10.3389\/fnins.2024.1439055.","journal-title":"Front Neurosci"},{"key":"3876_CR90","doi-asserted-by":"publisher","DOI":"10.1101\/2025.06.30.662477","author":"M-T Jeon","year":"2025","unstructured":"Jeon M-T, Kim D-H, Cogill SA, et al. Influenza A virus infection is associated with TDP-43 pathology and neuronal damage in the brain. bioRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.06.30.662477.","journal-title":"bioRxiv"},{"issue":"5","key":"3876_CR91","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00702-013-1125-7","volume":"121","author":"V Andreoli","year":"2014","unstructured":"Andreoli V, De Marco EV, Trecroci F, Cittadella R, Di Palma G, Gambardella A. Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer\u2019s disease. J Neural Transm (Vienna). 2014;121(5):533\u201342. https:\/\/doi.org\/10.1007\/s00702-013-1125-7.","journal-title":"J Neural Transm (Vienna)"},{"issue":"12","key":"3876_CR92","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1523\/JNEUROSCI.6389-11.2012","volume":"21","author":"HA Jurgens","year":"2012","unstructured":"Jurgens HA, Amancherla K, Johnson RW. Influenza infection induces neuroinflammation, alters hippocampal neuron morphology, and impairs cognition in adult mice. J Neurosci. 2012;21(12):3958\u201368. https:\/\/doi.org\/10.1523\/JNEUROSCI.6389-11.2012.","journal-title":"J Neurosci"},{"key":"3876_CR93","doi-asserted-by":"publisher","first-page":"648617","DOI":"10.3389\/fnins.2021.648617","volume":"15","author":"P Rawal","year":"2021","unstructured":"Rawal P, Zhao L. Sialometabolism in brain health and alzheimer\u2019s disease. Front Neurosci. 2021;15:648617. https:\/\/doi.org\/10.3389\/fnins.2021.648617.","journal-title":"Front Neurosci"},{"issue":"3","key":"3876_CR94","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s11357-023-00761-1","volume":"45","author":"C Fastenau","year":"2023","unstructured":"Fastenau C, Wickline JL, Smith S, et al. Increased alpha-2,6 sialic acid on microglia in amyloid pathology is resistant to oseltamivir. Geroscience. 2023;45(3):1539\u201355. https:\/\/doi.org\/10.1007\/s11357-023-00761-1.","journal-title":"Geroscience"},{"issue":"1","key":"3876_CR95","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12974-020-01741-4","volume":"19","author":"Y Yang","year":"2020","unstructured":"Yang Y, He Z, Xing Z, et al. Influenza vaccination in early Alzheimer\u2019s disease rescues amyloidosis and ameliorates cognitive deficits in APP\/PS1 mice by inhibiting regulatory T cells. J Neuroinflammation. 2020;19(1):65. https:\/\/doi.org\/10.1186\/s12974-020-01741-4.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"3876_CR96","doi-asserted-by":"publisher","first-page":"5476","DOI":"10.1038\/s41380-021-01138-6","volume":"26","author":"M Wainberg","year":"2021","unstructured":"Wainberg M, Luquez T, Koelle DM, et al. The viral hypothesis: how herpesviruses may contribute to Alzheimer\u2019s disease. Mol Psychiatry. 2021;26(10):5476\u201380. https:\/\/doi.org\/10.1038\/s41380-021-01138-6.","journal-title":"Mol Psychiatry"},{"key":"3876_CR97","doi-asserted-by":"publisher","unstructured":"De Francesco MA, Herpesviridae. Neurodegenerative disorders and autoimmune diseases: what is the relationship between them? Viruses. 2024;17(1). https:\/\/doi.org\/10.3390\/v16010133.","DOI":"10.3390\/v16010133"},{"key":"3876_CR98","doi-asserted-by":"publisher","first-page":"1597776","DOI":"10.3389\/fimmu.2025.1597776","volume":"16","author":"J Garcia Diaz","year":"2025","unstructured":"Garcia Diaz J, Park SJ, Legouez L, et al. Zika virus induces monocyte recruitment in the immunocompetent adult brain driving chronic inflammation. Front Immunol. 2025;16:1597776. https:\/\/doi.org\/10.3389\/fimmu.2025.1597776.","journal-title":"Front Immunol"},{"issue":"7","key":"3876_CR99","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/cid\/ciw878","volume":"1","author":"FM Lum","year":"2017","unstructured":"Lum FM, Low DK, Fan Y, et al. Zika virus infects human fetal brain microglia and induces inflammation. Clin Infect Dis. 2017;1(7):914\u201320. https:\/\/doi.org\/10.1093\/cid\/ciw878.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3876_CR100","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41420-022-00958-x","volume":"2","author":"SE Lee","year":"2022","unstructured":"Lee SE, Choi H, Shin N, et al. Zika virus infection accelerates Alzheimer\u2019s disease phenotypes in brain organoids. Cell Death Discov. 2022;2(1):153. https:\/\/doi.org\/10.1038\/s41420-022-00958-x.","journal-title":"Cell Death Discov"},{"issue":"4","key":"3876_CR101","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/1941874419845732","volume":"9","author":"E Bakradze","year":"2019","unstructured":"Bakradze E, Kirchoff KF, Antoniello D, et al. Varicella zoster virus vasculitis and adult cerebrovascular disease. Neurohospitalist. 2019;9(4):203\u20138. https:\/\/doi.org\/10.1177\/1941874419845732.","journal-title":"Neurohospitalist"},{"issue":"1","key":"3876_CR102","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10072-023-07038-7","volume":"45","author":"J Gao","year":"2024","unstructured":"Gao J, Feng L, Wu B, et al. The association between varicella zoster virus and dementia: a systematic review and meta-analysis of observational studies. Neurol Sci. 2024;45(1):27\u201336. https:\/\/doi.org\/10.1007\/s10072-023-07038-7.","journal-title":"Neurol Sci"},{"issue":"1","key":"3876_CR103","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12883-025-04500-1","volume":"22","author":"F Bastan","year":"2025","unstructured":"Bastan F, Saeedi-Moghaddam F, Rashidian M, Mirhosseini F, Mozhgani SH. Human herpesvirus 6 (HHV-6) infection and risk of Alzheimer\u2019s disease: a systematic review and meta-analysis. BMC Neurol. 2025;22(1):516. https:\/\/doi.org\/10.1186\/s12883-025-04500-1.","journal-title":"BMC Neurol"},{"issue":"6","key":"3876_CR104","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.neuron.2019.12.031","volume":"18","author":"MA Allnutt","year":"2020","unstructured":"Allnutt MA, Johnson K, Bennett DA, et al. Human herpesvirus 6 detection in alzheimer\u2019s disease cases and controls across multiple cohorts. Neuron. 2020;18(6):1027\u2013e10352. https:\/\/doi.org\/10.1016\/j.neuron.2019.12.031.","journal-title":"Neuron"},{"key":"3876_CR105","unstructured":"Global HIV, AIDS statistics \u2014 Fact sheet. &. 2024. UNAIDS; 2024. https:\/\/www.unaids.org\/en\/resources\/fact-sheet. Accessed 15 Jan 2025."},{"key":"3876_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/jjbc.2021.100936","author":"RK Infectious","year":"2021","unstructured":"Infectious RK. Etiology and amyloidosis in Alzheimer\u2019s disease: the puzzle continues. J Biol Chem. 2021. https:\/\/doi.org\/10.1016\/jjbc.2021.100936.","journal-title":"J Biol Chem"},{"key":"3876_CR107","doi-asserted-by":"publisher","first-page":"1129640","DOI":"10.3389\/fnagi.2023.1129640","volume":"15","author":"N Liu","year":"2023","unstructured":"Liu N, Jiang X, Li H. The viral hypothesis in Alzheimer\u2019s disease: SARS-CoV-2 on the cusp. Front Aging Neurosci. 2023;15:1129640. https:\/\/doi.org\/10.3389\/fnagi.2023.1129640.","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"3876_CR108","doi-asserted-by":"publisher","first-page":"NS20180203","DOI":"10.1042\/NS20180203","volume":"3","author":"HC Hunsberger","year":"2019","unstructured":"Hunsberger HC, Pinky PD, Smith W, Suppiramaniam V, Reed MN. The role of APOE4 in Alzheimer\u2019s disease: strategies for future therapeutic interventions. Neuronal Signal. 2019;3(2):NS20180203. https:\/\/doi.org\/10.1042\/NS20180203.","journal-title":"Neuronal Signal"},{"key":"3876_CR109","doi-asserted-by":"publisher","unstructured":"Mangold CA, Szpara ML. Persistent infection with herpes simplex virus 1 and alzheimer\u2019s disease-a call to study how variability in both virus and host may impact disease. Viruses. 2019;20(10). https:\/\/doi.org\/10.3390\/v11100966.","DOI":"10.3390\/v11100966"},{"issue":"8","key":"3876_CR110","doi-asserted-by":"publisher","first-page":"e2728","DOI":"10.1002\/brb3.2728","volume":"12","author":"O Uwishema","year":"2022","unstructured":"Uwishema O, Mahmoud A, Sun J, et al. Is Alzheimer\u2019s disease an infectious neurological disease? a review of the literature. Brain Behav. 2022;12(8):e2728. https:\/\/doi.org\/10.1002\/brb3.2728.","journal-title":"Brain Behav"},{"key":"3876_CR111","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fnagi.2018.00048","volume":"10","author":"SA Harris","year":"2018","unstructured":"Harris SA, Harris EA. Molecular mechanisms for herpes simplex virus type 1 pathogenesis in alzheimer\u2019s disease. Front Aging Neurosci. 2018;10:48. https:\/\/doi.org\/10.3389\/fnagi.2018.00048.","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"3876_CR112","doi-asserted-by":"publisher","first-page":"e1008596","DOI":"10.1371\/journal.ppat.1008596","volume":"16","author":"CE Seaks","year":"2020","unstructured":"Seaks CE, Wilcock DM. Infectious hypothesis of Alzheimer disease. PLoS Pathog. 2020;16(11):e1008596. https:\/\/doi.org\/10.1371\/journal.ppat.1008596.","journal-title":"PLoS Pathog"},{"issue":"Supplement2","key":"3876_CR113","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1093\/infdis\/jiae242","volume":"10","author":"A Onisiforou","year":"2024","unstructured":"Onisiforou A, Zanos P. From viral infections to alzheimer\u2019s disease: unveiling the mechanistic links through systems bioinformatics. J Infect Dis. 2024;10(Supplement2):S128\u201340. https:\/\/doi.org\/10.1093\/infdis\/jiae242.","journal-title":"J Infect Dis"},{"issue":"1","key":"3876_CR114","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/antiox15010066","volume":"15","author":"G Ayyubova","year":"2026","unstructured":"Ayyubova G, Bablu FE, Rahimli N, et al. Roles of reactive oxygen species in relationships between viral infections and alzheimer\u2019s disease and related dementia. Antioxidants. 2026;15(1):66. https:\/\/doi.org\/10.3390\/antiox15010066.","journal-title":"Antioxidants"},{"issue":"1","key":"3876_CR115","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s10571-025-01622-5","volume":"4","author":"A Mohabbat","year":"2025","unstructured":"Mohabbat A, Bannazadeh Baghi H. Chronic neuroplasticity changes following neurotropic viral infection: mechanisms and implications. Cell Mol Neurobiol. 2025;4(1):94. https:\/\/doi.org\/10.1007\/s10571-025-01622-5.","journal-title":"Cell Mol Neurobiol"},{"issue":"5","key":"3876_CR116","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1007\/s12035-023-03761-6","volume":"61","author":"P Wongchitrat","year":"2024","unstructured":"Wongchitrat P, Chanmee T, Govitrapong P. Molecular mechanisms associated with neurodegeneration of neurotropic viral infection. Mol Neurobiol. 2024;61(5):2881\u2013903. https:\/\/doi.org\/10.1007\/s12035-023-03761-6.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"3876_CR117","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12883-020-01776-3","volume":"28","author":"KH Lee","year":"2020","unstructured":"Lee KH, Kwon DE, Do Han K, La Y, Han SH. Association between cytomegalovirus end-organ diseases and moderate-to-severe dementia: a population-based cohort study. BMC Neurol. 2020;28(1):216. https:\/\/doi.org\/10.1186\/s12883-020-01776-3.","journal-title":"BMC Neurol"},{"issue":"17","key":"3876_CR118","doi-asserted-by":"publisher","first-page":"8713","DOI":"10.1039\/d3cs00878a","volume":"27","author":"Y Tang","year":"2024","unstructured":"Tang Y, Zhang Y, Zhang D, Liu Y, Nussinov R, Zheng J. Exploring pathological link between antimicrobial and amyloid peptides. Chem Soc Rev. 2024;27(17):8713\u201363. https:\/\/doi.org\/10.1039\/d3cs00878a.","journal-title":"Chem Soc Rev"},{"issue":"9","key":"3876_CR119","doi-asserted-by":"publisher","first-page":"pgad282","DOI":"10.1093\/pnasnexus\/pgad282","volume":"2","author":"C Di Primio","year":"2023","unstructured":"Di Primio C, Quaranta P, Mignanelli M, et al. Severe acute respiratory syndrome coronavirus 2 infection leads to Tau pathological signature in neurons. PNAS Nexus. 2023;2(9):pgad282. https:\/\/doi.org\/10.1093\/pnasnexus\/pgad282.","journal-title":"PNAS Nexus"},{"issue":"1","key":"3876_CR120","doi-asserted-by":"publisher","first-page":"115109","DOI":"10.1016\/j.celrep.2024.115109","volume":"28","author":"VR Hyde","year":"2025","unstructured":"Hyde VR, Zhou C, Fernandez JR, et al. Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer\u2019s disease. Cell Rep. 2025;28(1):115109. https:\/\/doi.org\/10.1016\/j.celrep.2024.115109.","journal-title":"Cell Rep"},{"issue":"868","key":"3876_CR121","doi-asserted-by":"publisher","first-page":"eado6430","DOI":"10.1126\/scisignal.ado6430","volume":"07","author":"DM Cairns","year":"2025","unstructured":"Cairns DM, Smiley BM, Smiley JA, et al. Repetitive injury induces phenotypes associated with Alzheimer\u2019s disease by reactivating HSV-1 in a human brain tissue model. Sci Signal. 2025;07(868):eado6430. https:\/\/doi.org\/10.1126\/scisignal.ado6430.","journal-title":"Sci Signal"},{"key":"3876_CR122","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3389\/fnins.2019.00463","volume":"13","author":"JS Cristovao","year":"2019","unstructured":"Cristovao JS, Gomes CM. S100 Proteins in alzheimer\u2019s disease. Front Neurosci. 2019;13:463. https:\/\/doi.org\/10.3389\/fnins.2019.00463.","journal-title":"Front Neurosci"},{"issue":"5","key":"3876_CR123","doi-asserted-by":"publisher","first-page":"107306","DOI":"10.1016\/j.jbc.2024.107306","volume":"300","author":"DC Shippy","year":"2024","unstructured":"Shippy DC, Oliai SF, Ulland TK. Zinc utilization by microglia in Alzheimer\u2019s disease. J Biol Chem. 2024;300(5):107306. https:\/\/doi.org\/10.1016\/j.jbc.2024.107306.","journal-title":"J Biol Chem"},{"key":"3876_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)70016-5","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation Alzheimer\u2019s disease. 2015. https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5.","journal-title":"Neuroinflammation Alzheimer\u2019s disease"},{"issue":"1","key":"3876_CR125","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/path.2449","volume":"217","author":"MA Wozniak","year":"2009","unstructured":"Wozniak MA, Mee AP, Itzhaki RF. Herpes simplex virus type 1 DNA is located within Alzheimer\u2019s disease amyloid plaques. J Pathol. 2009;217(1):131\u20138. https:\/\/doi.org\/10.1002\/path.2449.","journal-title":"J Pathol"},{"key":"3876_CR126","doi-asserted-by":"publisher","unstructured":"Cai Z, Qiao PF, Wan CQ, Cai M, Zhou NK, Li Q. Role of blood-brain barrier in Alzheimer\u2019s disease. 2018. https:\/\/doi.org\/10.3233\/JAD-180098.","DOI":"10.3233\/JAD-180098"},{"key":"3876_CR127","doi-asserted-by":"publisher","unstructured":"Wongchitrat P, Chanmee T, Govitrapong P. Molecular mechanisms associated with neurodegeneration of neurotropic viral infection. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-023-03761-6.","DOI":"10.1007\/s12035-023-03761-6"},{"key":"3876_CR128","doi-asserted-by":"publisher","unstructured":"Al-Obaidi MMJ, Muthanna A, Desa MNM. Nipah virus neurotropism: insights into blood-brain barrier disruption. J Integr Neurosci. https:\/\/doi.org\/10.31083\/j.jin2305090.","DOI":"10.31083\/j.jin2305090"},{"key":"3876_CR129","doi-asserted-by":"publisher","unstructured":"Chen J, Lei Z, et al. Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-\u03b2-associated pathology in APP\/PS1 mouse model of Alzheimer\u2019s disease. 2023. https:\/\/doi.org\/10.1038\/s41398-023-02692-z.","DOI":"10.1038\/s41398-023-02692-z"},{"key":"3876_CR130","doi-asserted-by":"publisher","unstructured":"Nuovo GJ, Suster D, Sawant D, et al. The amplification of CNS damage in Alzheimer\u2019s disease due to SARS-CoV2 infection. https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.152057.","DOI":"10.1016\/j.anndiagpath.2022.152057"},{"key":"3876_CR131","doi-asserted-by":"publisher","unstructured":"Kadri F, Pacifici M, Wilk A, et al. HIV-1-Tat protein inhibits SC35-mediated tau exon 10 inclusion through up-regulation of DYRK1A kinase. https:\/\/doi.org\/10.1074\/jbc.M115.675751.","DOI":"10.1074\/jbc.M115.675751"},{"key":"3876_CR132","doi-asserted-by":"publisher","unstructured":"Sun Y, Cai M, Liang Y, Zhang Y. Disruption of blood-brain barrier: effects of HIV Tat on brain microvascular endothelial cells and tight junction proteins. https:\/\/doi.org\/10.1007\/s13365-023-01179-3.","DOI":"10.1007\/s13365-023-01179-3"},{"key":"3876_CR133","doi-asserted-by":"publisher","unstructured":"Hosseini S, Michaelsen-Preusse K, Schughart K, Korte M. Long-term consequence of non-neurotropic h3n2 influenza a virus infection for the progression of alzheimer\u2019s disease symptoms. 2021. https:\/\/doi.org\/10.3389\/fncel.2021.643650.","DOI":"10.3389\/fncel.2021.643650"},{"key":"3876_CR134","doi-asserted-by":"publisher","unstructured":"Andreoli V, De Marco EV, Trecroci F, Cittadella R, Di Palma G, Gambardella A. Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer\u2019s disease. 2014. https:\/\/doi.org\/10.1007\/s00702-013-1125-7.","DOI":"10.1007\/s00702-013-1125-7"},{"key":"3876_CR135","doi-asserted-by":"publisher","DOI":"10.1101\/2025.07.31.667659","author":"MO Lunn","year":"2025","unstructured":"Lunn MO, Lengacher NA, Hake-Volling Q, et al. Elevated brain \u03b1-synuclein, phosphorylated-tau, and oxidative stress in mice that survived influenza A pneumonitis. bioRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.07.31.667659.","journal-title":"bioRxiv"},{"key":"3876_CR136","doi-asserted-by":"publisher","unstructured":"Cousins O, Schubert JJ, Chandra A, et al. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal\/multi-tracer PET\/MRI imaging study with influenza vaccine immune challenge. 2023. https:\/\/doi.org\/10.1186\/s12974-023-02945-0.","DOI":"10.1186\/s12974-023-02945-0"},{"key":"3876_CR137","doi-asserted-by":"publisher","unstructured":"Robinson SR, Dobson C, Lyons J. Challenges and directions for the pathogen hypothesis of Alzheimer\u2019s disease. Neurobiol Aging https:\/\/doi.org\/10.1016\/j.neurobiolaging.2003.12.022.","DOI":"10.1016\/j.neurobiolaging.2003.12.022"},{"key":"3876_CR138","doi-asserted-by":"publisher","first-page":"1434945","DOI":"10.3389\/fnins.2024.1434945","volume":"18","author":"S Fernandes","year":"2024","unstructured":"Fernandes S, Revanna J, Pratt J, Hayes N, Marchetto MC, Gage FH. Modeling Alzheimer\u2019s disease using human cell derived brain organoids and 3D models. Front Neurosci. 2024;18:1434945. https:\/\/doi.org\/10.3389\/fnins.2024.1434945.","journal-title":"Front Neurosci"},{"key":"3876_CR139","doi-asserted-by":"publisher","first-page":"1240945","DOI":"10.3389\/fnagi.2023.1240945","volume":"15","author":"TZ Arabi","year":"2023","unstructured":"Arabi TZ, Alabdulqader AA, Sabbah BN, Ouban A. Brain-inhabiting bacteria and neurodegenerative diseases: the brain microbiome theory. Front Aging Neurosci. 2023;15:1240945. https:\/\/doi.org\/10.3389\/fnagi.2023.1240945.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"3876_CR140","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4149\/av_2018_102","volume":"62","author":"MMJ Al-Obaidi","year":"2018","unstructured":"Al-Obaidi MMJ, Bahadoran A, Wang SM, Manikam R, Raju CS, Sekaran SD. Disruption of the blood brain barrier is vital property of neurotropic viral infection of the central nervous system. Acta Virol. 2018;62(1):16\u201327. https:\/\/doi.org\/10.4149\/av_2018_102.","journal-title":"Acta Virol"},{"key":"3876_CR141","doi-asserted-by":"publisher","unstructured":"Vijayan M, Yin L, Reddy PH, Benamar K. Behavioral Evidence for a Tau and HIV-gp120 Interaction. Int J Mol Sci. 2022;15(10). https:\/\/doi.org\/10.3390\/ijms23105514.","DOI":"10.3390\/ijms23105514"},{"issue":"52","key":"3876_CR142","doi-asserted-by":"publisher","first-page":"30931","DOI":"10.1074\/jbc.M115.675751","volume":"25","author":"F Kadri","year":"2015","unstructured":"Kadri F, Pacifici M, Wilk A, et al. HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase. J Biol Chem. 2015;25(52):30931\u201346. https:\/\/doi.org\/10.1074\/jbc.M115.675751.","journal-title":"J Biol Chem"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03876-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03876-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03876-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T23:18:25Z","timestamp":1785712705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03876-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":142,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3876"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03876-2","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All author have consented for the publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"265"}}